Impact of rokitamycin, a new 16-membered macrolide, on serum theophylline.
Side effects have been observed when 14-membered macrolides, erythromycin and troleandromycin, have been prescribed concurrently in patients receiving therapeutic doses of theophylline. Rokitamycin is a new 16-membered macrolide antibiotic. We have evaluated its effect on theophylline serum concentrations in 12 adult patients suffering from chronic obstructive pulmonary disease. Initially, six patients were treated for four consecutive days with theophylline as sustained-release formulation in the amount of 600 mg daily; six other patients received for four consecutive days a short term intravenous infusion of 240 mg aminophylline, given over a period of 30 min twice daily. On the last day, blood samples were taken for theophylline determination. Theophylline concentrations were measured serially for 12 hours after oral formulation and 4 hours after aminophylline by enzyme immunoassay technique. Subsequently, while theophylline and aminophylline treatments were continued at the same dosage, each patient received in addition rokitamycin tablets, 400 mg every 12 hours. After seven days of this combined medication, the serial assays of serum theophylline were repeated at the same time intervals as before. Concomitant administration of therapeutic doses of rokitamycin did not affect significantly the steady-state pharmacokinetics of oral theophylline and did not alter the (pseudo-) steady-state pharmacokinetics of intravenous aminophylline, showing that the two drugs may be coadministered without any theophylline dose adjustment.
Cazzola
M
M
Institute of Pharmacology and Toxicology, 1st Medical School, Federico II University, Naples, Italy.
Matera
M G
MG
Paternò
E
E
Scaglione
F
F
Santangelo
G
G
Rossi
F
F
D000368:Aged; D000628:Aminophylline / Q000097:blood; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000097:blood / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D015644:Miocamycin / Q000031:analogs & derivatives* / Q000494:pharmacology; D013806:Theophylline / Q000097:blood*
D000900:Anti-Bacterial Agents; D000628:Aminophylline; D015644:Miocamycin; D013806:Theophylline; C033383:rokitamycin